Home › SEC Filings › Press Releases
Press Releases
All Current Report (8-K)Annual Report (10-K)Quarterly Report (10-Q)Form 4 Insider TradesSC 13D Beneficial Ownership13F Institutional HoldingsPress ReleasesInsider Cluster ActivityInsider Buy Activity
Theme?
All themes Artificial IntelligenceSemiconductorsQuantum ComputingSpace & SatellitesRobotics & AutomationElectric VehiclesClean & Renewable EnergyBattery & Energy StorageNuclear & FusionCybersecurityCloud & SaaSFintech & PaymentsCrypto & BlockchainGenomics & Gene EditingBiotech & Drug DiscoveryE-commerce & PlatformsStreaming & Digital MediaGaming & EsportsDefense TechCannabis
| Ticker | Type | Sentiment | Impact | Summary | Date |
|---|---|---|---|---|---|
| HIT | PRESS-RELEASE | bearish | 6/10 | Health In Tech reported Q2 2026 revenue of $8.1M (down 13.5% YoY from $9.3M) and a net loss of $2.5M ($-0.04 EPS), rever | Aug 13, 2026 |
| RNA | PRESS-RELEASE | neutral | 4/10 | Atrium Therapeutics reported Q2 2026 collaboration revenue of $3.0M, a net loss of -$1.18 per share, and highlighted FDA | Aug 13, 2026 |
| LFT | PRESS-RELEASE | bearish | 7/10 | Lument Finance Trust reported a GAAP net loss of $9.2M for Q2 2026, with Distributable Loss of $5.3M ($0.10/share), miss | Aug 13, 2026 |
| BAFN | PRESS-RELEASE | bearish | 8/10 | BayFirst Financial Corp. reported a net loss of $32.7 million ($8.05 per share) for Q2 2026, driven by a $41.5 million a | Aug 13, 2026 |
| ASMB | PRESS-RELEASE | bullish | 6/10 | Assembly Biosciences reported Q2 2026 EPS of -$0.20, beating consensus of -$0.53 by 62.3%, and collaboration revenue of | Aug 13, 2026 |
| MDXH | PRESS-RELEASE | mixed | 5/10 | mdxhealth reported Q2 2026 revenue of $27.2M (+16% YoY), beating consensus estimates, but net loss widened to $9.5M and | Aug 13, 2026 |
| KOD | PRESS-RELEASE | neutral | 6/10 | Kodiak Sciences reported Q2 2026 net loss of $65.6M ($1.05/share), wider than the $54.3M loss in Q2 2025, with R&D spend | Aug 13, 2026 |
| IDAI | PRESS-RELEASE | bearish | 6/10 | Trust Stamp reported Q1 2026 EPS of -$0.42, a 23.5% miss vs consensus of -$0.34. Revenue for the six months ended June 3 | Aug 13, 2026 |
| IPWR | PRESS-RELEASE | neutral | 5/10 | Ideal Power reported Q2 2026 results with revenue of $5,800 (up from $1,275 YoY) and a net loss of $3.4M ($0.20/share), | Aug 13, 2026 |
| SPCB | PRESS-RELEASE | bullish | 6/10 | GAAP EPS was $0.20. Record EBITDA of $4.0M (+58% YoY) and strong U.S. electronic monitoring recurring revenue growth (AR | Aug 13, 2026 |
| PH | PRESS-RELEASE | bullish | 6/10 | Parker-Hannifin completed its acquisition of Filtration Group Corporation, a deal expected to add ~$1.8B to fiscal 2027 | Aug 13, 2026 |
| LINK | PRESS-RELEASE | neutral | 4/10 | Interlink Electronics reported Q2 2026 revenue of $3.77M, up 10.4% YoY, and net income of $248K vs $100K a year ago. The | Aug 13, 2026 |
| QUCY | PRESS-RELEASE | neutral | 3/10 | Quantum Cyber published a whitepaper detailing its patent-pending Quantum Photonic Antenna architecture, an early-stage | Aug 13, 2026 |
| LITB | PRESS-RELEASE | mixed | 5/10 | LightInTheBox completed a $5.49M private placement, issuing 21.4M ordinary shares at $0.2567/share ($3.08/ADS). Chairman | Aug 13, 2026 |
| TTEC | PRESS-RELEASE | neutral | 4/10 | TTEC announced a one-year, $21 million contract from the IRS to provide contact center enterprise infrastructure softwar | Aug 13, 2026 |
| POWW | PRESS-RELEASE | neutral | 2/10 | Outdoor Holding Company (POWW) declared a regular quarterly cash dividend of $0.546875 per share on its 8.75% Series A C | Aug 13, 2026 |
| AAON | PRESS-RELEASE | neutral | 2/10 | AAON declared a regular quarterly cash dividend of $0.10 per share ($0.40 annually), payable September 25, 2026, to hold | Aug 13, 2026 |
| CMND | PRESS-RELEASE | bullish | 6/10 | Clearmind Medicine received DSMB approval to advance its Phase I/II trial of CMND-100 for Alcohol Use Disorder to Parts | Aug 13, 2026 |
| HCTI | PRESS-RELEASE | bearish | 7/10 | Healthcare Triangle reported Q2 2026 revenue of $9.19M (+158% YoY) and gross profit of $2.07M (+322% YoY), driven by the | Aug 13, 2026 |
| CADL | PRESS-RELEASE | bullish | 7/10 | Candel Therapeutics reported Q2 2026 financial results with a net loss of $38.9M ($0.52 per share), significantly wider | Aug 13, 2026 |
| MGTX | PRESS-RELEASE | neutral | 5/10 | MeiraGTx reported Q2 2026 GAAP net income of $160.7M ($1.71 diluted EPS) vs a net loss of $38.8M ($-0.48) a year ago, dr | Aug 13, 2026 |
| NUWE | PRESS-RELEASE | bearish | 7/10 | Nuwellis reported Q2 2026 net sales of $2.0M (+14% YoY) and a net loss of $4.8M, with gross margin improving to 76% from | Aug 13, 2026 |
| REKR | PRESS-RELEASE | neutral | 5/10 | Rekor Systems reported Q2 2026 revenue of $12.7M, slightly above the $12.6M consensus, with a GAAP EPS of $0.00 versus t | Aug 13, 2026 |
| DKI | PRESS-RELEASE | bearish | 6/10 | DarkIris reported H1 FY2026 revenue of $5.93M (+13.9% YoY) but swung to a net loss of $1.90M from net income of $0.91M a | Aug 13, 2026 |
| SGRP | PRESS-RELEASE | mixed | 5/10 | SPAR Group reported Q2 2026 revenue of $36.9M, down 4.5% YoY, but returned to profitability with net income of $409K vs | Aug 13, 2026 |
| BTBT | PRESS-RELEASE | neutral | 5/10 | Bit Digital reported Q2 2026 revenue of $32.1M, up 15% sequentially, but a net loss of $(107.2)M or $(0.31) per diluted | Aug 13, 2026 |
| GRCE | PRESS-RELEASE | mixed | 5/10 | Grace Therapeutics reported a net loss of $15.8M for Q1 FY2027 (June 30, 2026), driven by a $13.5M impairment of IPR&D f | Aug 13, 2026 |
| ARTL | PRESS-RELEASE | neutral | 4/10 | Artelo Biosciences reported Q2 2026 net loss of $2.4M ($0.89/share) vs $3.2M in Q2 2025, with R&D expenses halved to $0. | Aug 13, 2026 |
| VERX | PRESS-RELEASE | bearish | 6/10 | Vertex Inc. reported Q2 2026 EPS of $0.20, missing consensus of $0.22 by 9.1%, on revenue of $209.8M (consensus $209.8M, | Aug 13, 2026 |
| MSC | PRESS-RELEASE | bearish | 6/10 | Studio City reported Q2 2026 results with total operating revenues of $164.6M, down 13.4% YoY from $190.1M, driven by so | Aug 13, 2026 |